PT Pyridam Farma Tbk (ISX:PYFA) Short-Term Debt: Rp986,433 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
65 GF Score
Price Rp214.00
GF Value Rp230.48
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Short-Term Debt?

PT Pyridam Farma Tbk ISX:PYFA 65 Short-Term Debt is Rp986,433 Mil as of Jun. 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 65/100 and a GF Value™ of Rp230.48 (Fairly Valued). The stock has 8 warning signs investors should review.

PT Pyridam Farma Tbk's Short-Term Debt for the quarter that ended in Jun. 2026 was Rp986,433 Mil.

PT Pyridam Farma Tbk's quarterly Short-Term Debt increased from Dec. 2025 (Rp374,599 Mil) to Mar. 2026 (Rp880,806 Mil) and increased from Mar. 2026 (Rp880,806 Mil) to Jun. 2026 (Rp986,433 Mil).

PT Pyridam Farma Tbk's annual Short-Term Debt increased from Dec. 2023 (Rp145,485 Mil) to Dec. 2024 (Rp623,850 Mil) but then declined from Dec. 2024 (Rp623,850 Mil) to Dec. 2025 (Rp374,599 Mil).

PT Pyridam Farma Tbk Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PT Pyridam Farma Tbk Short-Term Debt Related Terms

PT Pyridam Farma Tbk Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Short-Term Debt Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80,858.24 154,131.08 145,485.09 623,849.93 374,598.69

PT Pyridam Farma Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 732,546.88 742,098.93 374,598.69 880,806.09 986,432.63
ISX:PYFA
65GF Score
PT Pyridam Farma Tbk ISX:PYFA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of Rp986,433 Mil mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Short-Term Debt of Rp986,433 Mil as of Jun. 2026.
Is PT Pyridam Farma Tbk's Short-Term Debt too high?
PT Pyridam Farma Tbk's current Short-Term Debt is Rp986,433 Mil. Overall, PT Pyridam Farma Tbk has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Short-Term Debt compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Short-Term Debt of Rp986,433 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Pyridam Farma Tbk's current Short-Term Debt is Rp986,433 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp230.48, compared to a current price of Rp214.00 — trading 7.2% below its estimated fair value. The current Short-Term Debt is Rp986,433 Mil. PT Pyridam Farma Tbk's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Short-Term Debt is Rp986,433 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued. The current stock price of Rp214.00 is trading 7.2% below its estimated GF Value™ of Rp230.48. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Short-Term Debt: Rp986,433 Mil
  • GF Value™: Rp230.48 vs. price of Rp214.00 (7.2% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
65GF Score

Get the complete analysis for ISX:PYFA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp214.00
Price
Rp230.48
GF Value